Dynamics of the level of calprotectin in patients with rheumatoid arthritis during rituximab biosimilar (Acellbia “Biocad”) therapy

Objective. To study the relationship between the level of calprotectin (CP) and RA activity, the level of acute phase reactants, proinflammatory cytokines, chemokines and growth factors, to assess its dynamics during rituximab (RTM) biosimilar therapy.Material and methods. 20 patients with RA were e...

Full description

Bibliographic Details
Main Authors: A. S. Avdeeva, M. V. Cherkasova, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2021-09-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3056